All News

Emerging Pharma Leaders 2011

What do our genetics tell us about our predisposition to certain diseases?

Sizing Up For Success

The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance

A Silver Lining

Ilogistica has built a brand new warehouse facility with the latest technology to keep up with outsourcing demands

Espacio Riesco has adapted to the needs of pharma companies with the largest event space in Chile

Castellani Takes Charge at PhRMA

Boehringer Ingelheim's PICASSO program helps it focus on engaging industry stakeholders to improve patient care

Ferring finds a new approach to communicate its value offering

Ipsen is redefining a standard for success in innovation with its local Dutch affiliate

Prix Galien 2011 sponsorship brochure

Hotels, Convention Centers and Convention & Visitor Bureaus

The Promise Of Translational Medicine

The mediterranean nation has endeared itself to foreign businesses over the past decades, adtively positioning itself as an appealing epicenter of global pharma interest

PharmExec edit calendar revised and smaller size

After many years of building up an impressive resource base, the industry is finally ready to take advantage of the wave of enthusiasm and interest surounding pharma and biotech that is sweeping the nation

June 2010 Sworn Statement

Once silent, an emerging market raises its voice

PharmExec 2011 online e-media rates

September 21, 2010.

September 08, 2010.

In a huge blow to Eli Lilly's Alzheimer's pipeline, the drug giant was forced to end two clinical trials due to the fact that the treatment was actually making patients' memory recall worse.

Head-and-neck cancer treatment trial flops in Phase 3 trials causing Amgen stock to drop. The first-line therapy failed first and secondary goals compared with chemotherapy alone.